Donald A. Bergstrom
Chief Medical Officer, Mersana Therapeutics (United States).
Companies
- Relay TherapeuticsPresident Jan 31, 2022 to now1
- Fusion PharmaceuticalsBoard member Apr 1, 2021 to Jun 4, 20242
- Relay TherapeuticsOfficer Jul 15, 2020 to Dec 27, 20213
- Mersana Therapeutics (United States)Chief Medical Officer Jun 27, 2017 to Feb 6, 20184
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Relay Therapeutics RLAY399,130 shares5$6.8M at $17.07Sep 8, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 8, 2026Sold 8,530 shares at $18.97 of Relay Therapeutics5
- Jul 28, 2026Sold 2,237 shares at $18.61 of Relay Therapeutics6
- Jul 6, 2026Sold 8,660 shares at $18.71 of Relay Therapeutics7
- Jun 22, 2026Sold 93,456 shares at $16.94 of Relay Therapeutics8
- Jun 22, 2026Exercised options 93,456 shares at $4.12 of Relay Therapeutics8
- Apr 28, 2026Sold 1,490 shares at $14.79 of Relay Therapeutics9
- Jan 28, 2026Sold 2,686 shares at $8.45 of Relay Therapeutics10
- Jan 27, 2026Sold 18,895 shares at $7.62 of Relay Therapeutics10
- Oct 28, 2025Sold 30,897 shares at $7.29 of Relay Therapeutics11
- Jul 29, 2025Sold 26,701 shares at $3.68 of Relay Therapeutics12
- Jul 28, 2025Sold 4,069 shares at $3.74 of Relay Therapeutics12
- Apr 30, 2025Sold 27,472 shares at $3.00 of Relay Therapeutics13
- Apr 28, 2025Sold 4,090 shares at $3.17 of Relay Therapeutics13
- Mar 27, 2025Sold 986 shares at $2.84 of Relay Therapeutics14
- Jan 30, 2025Sold 30,823 shares at $4.42 of Relay Therapeutics15
- Jan 29, 2025Sold 46,407 shares at $4.55 of Relay Therapeutics15
- Jan 28, 2025Granted 176,400 shares of Relay Therapeutics15
- Jan 28, 2025Sold 3,220 shares at $4.63 of Relay Therapeutics15
- Dec 27, 2024Sold 657 shares at $4.38 of Relay Therapeutics16
- Oct 28, 2024Sold 2,688 shares at $6.06 of Relay Therapeutics17
- Sep 27, 2024Sold 648 shares at $7.51 of Relay Therapeutics18
- Jul 29, 2024Sold 2,698 shares at $8.85 of Relay Therapeutics19
- Jun 27, 2024Sold 648 shares at $6.26 of Relay Therapeutics20
- Apr 29, 2024Sold 2,686 shares at $6.38 of Relay Therapeutics21
- Mar 27, 2024Sold 765 shares at $7.70 of Relay Therapeutics22
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRelay Therapeutics, President
- 2SEC EDGARFusion Pharmaceuticals, Board member
- 3SEC EDGARRelay Therapeutics, Officer
- 4
- 5
- 6SEC EDGARForm 4 filed Jul 30, 2026
- 7SEC EDGARForm 4 filed Jul 8, 2026
- 8SEC EDGARForm 4 filed Jun 24, 2026
- 9SEC EDGARForm 4 filed Apr 30, 2026
- 10SEC EDGARForm 4 filed Jan 29, 2026
- 11SEC EDGARForm 4 filed Oct 30, 2025
- 12SEC EDGARForm 4 filed Jul 30, 2025
- 13SEC EDGARForm 4 filed Apr 30, 2025
- 14SEC EDGARForm 4 filed Mar 31, 2025
- 15SEC EDGARForm 4 filed Jan 30, 2025
- 16SEC EDGARForm 4 filed Dec 31, 2024
- 17SEC EDGARForm 4 filed Oct 30, 2024
- 18SEC EDGARForm 4 filed Oct 1, 2024
- 19SEC EDGARForm 4 filed Jul 31, 2024
- 20SEC EDGARForm 4 filed Jul 1, 2024
- 21SEC EDGARForm 4 filed Apr 29, 2024
- 22SEC EDGARForm 4 filed Mar 29, 2024